ATCT-10HIGH-DOSE CYTARABINE SALVAGE THERAPY FOR RECURRENT PRIMARY CNS LYMPHOMA

Lenalidomide monotherapy as salvage treatment for recurrent primary CNS lymphoma.

Prospective trial on topotecan salvage therapy in primary CNS lymphoma.

BACKGROUND Standard salvage therapy has not been established for recurrent primary central nervous system lymphoma (PCNSL). We report the final results of a prospective study on topotecan chemotherapy in relapsed or refractory PCNSL. PATIENTS AND METHODS The study included 27 patients with a median age of 51 years and an ECOG performance status of 2. Fourteen patients were refractory to the l...

Salvage chemotherapy with R-BAD (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary CNS lymphoma

disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation. Haematologica 2005;90:1672-9. 2. Osawa R, Singh N. Cytomegalovirus infection in critically ill patients: a systematic review. Crit Care 2009;13:R68. 3. Torres HA, Aguilera E, Safdar A, et al. Fatal cytomegalovirus pneumonia in patients with haematological malignancies: an autopsy-base...

Dose intensity and autologous stem cell transplantation as salvage therapy for pediatric primary CNS malignancies

License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be f...

Salvage therapy for Hodgkin's lymphoma.

Hodgkin's lymphoma (HL) is a clonal lymphoid malignancy that affects over 7000 patients in the United States annually. The disease remains one of the great success stories in the recent history of cancer treatment. More than 80% of HL patients will be expected to be long-term survivors because of recent advances in radiation therapy and combined chemotherapy. However, for the subset of patients...